This document describes a study that used gene expression analysis to identify genes that are differentially expressed during Lassa virus infection. Researchers took blood samples from infected non-human primates before infection and 3 days post-infection. They used microarrays to compare gene expression between the two time points. Many interferon-induced genes were found to be upregulated at 3 days post-infection, indicating an antiviral response. Some genes also showed Lassa-specific expression patterns. The researchers aim to validate these findings experimentally to better understand Lassa virus pathogenesis and diagnosis.
NMDA receptors play crucial roles in excitatory synaptic transmission. Rare variants in genes that encode receptor subunits are associated with several intractable neurodevelopmental disorders, including developmental and epileptic encephalopathy (DEE). To extend understanding of these intractable childhood diseases, we have begun to model these variants in laboratory mice.
Models studied so far are a constitutive knockin for GRIN2A variant p.Ser644Gly (S644G) based on one case, and a GRIN2D variant, p.Val667Ile (V667I), noted in at least three unrelated cases. Homozygous and heterozygous Grin2a S644G mice exhibit altered hippocampal morphology at 2 weeks, and homozygotes exhibit lethal tonic-clonic seizures in week 3. Heterozygotes have a normal lifespan without spontaneous seizures, but display a variety of distinct features including
resistance to electrically induced limbic seizures, as well as hyperactivity and repetitive and reduced anxiety behaviors. Multielectrode recordings of mutant neuronal networks reveal hyperexcitability and altered bursting and synchronicity of both mutant genotypes. When expressed in heterologous cells, mutant receptors exhibit enhanced NMDAR agonist potency and slow deactivation following rapid removal of glutamate, as occurs at synapses. Consistent with this, NMDAR-mediated synaptic currents in hippocampal slices from mutant mice show a prolonged deactivation time course. Standard antiepileptic drug monotherapy was ineffective in the patient, but combined treatment of NMDAR antagonists with antiepileptic drugs substantially reduced the seizure burden albeit without appreciable developmental improvement. Chronic treatment of homozygous mutant mouse pups with NMDAR antagonists delayed the onset of lethal seizures but did not prevent them.
Grin2d V667I knockin mice are at an earlier stage of study. In contrast to Grin2a S644G, V667I heterozygous mice are severely impaired and suffer from lethal tonic-clonic seizures with an onset from about 18 days to 3 months. The impairment precludes natural mating such that the line needs to be propagated by ovary transplantation. Young heterozygotes adults in video-EEG also exhibit very frequent interictal epileptiform spiking and spike-wave discharge activity, resembling absence seizures. Preliminary histology shows significant pyknotic nuclei appearing to evidence
cell death in the cerebral cortex. Pup developmental milestones, while not evidencing significant developmental delay, show unusual features including excessive maternal separation induced pup vocalization. Further studies are ongoing. Together these efforts illustrate the power of modelling severe neurodevelopmental seizure disorders using multiple experimental modalities and suggest their utility in identifying and evaluating new therapies.
Bioinformatics core services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
Bioinformatics core services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
Bioinformatics Core Services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
A simple presentation on the Lassa fever endemic in Nigeria - from its first discovery in a town called Lassa in northeastern Nigeria, the mode of transmission, to the control and prevention measures that can be applied to curbing the spread of the virus. Suitable for rural sensitization.
Excerpt from CDC -- [Signs & symptoms]
Signs and symptoms of Lassa fever typically occur 1-3 weeks after the patient comes into contact with the virus. For the majority of Lassa fever virus infections (approximately 80%), symptoms are mild and are undiagnosed. Mild symptoms include slight fever, general malaise and weakness, and headache. In 20% of infected individuals, however, disease may progress to more serious symptoms including hemorrhaging (in gums, eyes, or nose, as examples), respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, and shock. Neurological problems have also been described, including hearing loss, tremors, and encephalitis. Death may occur within two weeks after symptom onset due to multi-organ failure.
The most common complication of Lassa fever is deafness. Various degrees of deafness occur in approximately one-third of infections, and in many cases hearing loss is permanent. As far as is known, severity of the disease does not affect this complication: deafness may develop in mild as well as in severe cases.
Approximately 15%-20% of patients hospitalized for Lassa fever die from the illness. However, only 1% of all Lassa virus infections result in death. The death rates for women in the third trimester of pregnancy are particularly high. Spontaneous abortion is a serious complication of infection with an estimated 95% mortality in fetuses of infected pregnant mothers.
Because the symptoms of Lassa fever are so varied and nonspecific, clinical diagnosis is often difficult. Lassa fever is also associated with occasional epidemics, during which the case-fatality rate can reach 50% in hospitalized patients.
NMDA receptors play crucial roles in excitatory synaptic transmission. Rare variants in genes that encode receptor subunits are associated with several intractable neurodevelopmental disorders, including developmental and epileptic encephalopathy (DEE). To extend understanding of these intractable childhood diseases, we have begun to model these variants in laboratory mice.
Models studied so far are a constitutive knockin for GRIN2A variant p.Ser644Gly (S644G) based on one case, and a GRIN2D variant, p.Val667Ile (V667I), noted in at least three unrelated cases. Homozygous and heterozygous Grin2a S644G mice exhibit altered hippocampal morphology at 2 weeks, and homozygotes exhibit lethal tonic-clonic seizures in week 3. Heterozygotes have a normal lifespan without spontaneous seizures, but display a variety of distinct features including
resistance to electrically induced limbic seizures, as well as hyperactivity and repetitive and reduced anxiety behaviors. Multielectrode recordings of mutant neuronal networks reveal hyperexcitability and altered bursting and synchronicity of both mutant genotypes. When expressed in heterologous cells, mutant receptors exhibit enhanced NMDAR agonist potency and slow deactivation following rapid removal of glutamate, as occurs at synapses. Consistent with this, NMDAR-mediated synaptic currents in hippocampal slices from mutant mice show a prolonged deactivation time course. Standard antiepileptic drug monotherapy was ineffective in the patient, but combined treatment of NMDAR antagonists with antiepileptic drugs substantially reduced the seizure burden albeit without appreciable developmental improvement. Chronic treatment of homozygous mutant mouse pups with NMDAR antagonists delayed the onset of lethal seizures but did not prevent them.
Grin2d V667I knockin mice are at an earlier stage of study. In contrast to Grin2a S644G, V667I heterozygous mice are severely impaired and suffer from lethal tonic-clonic seizures with an onset from about 18 days to 3 months. The impairment precludes natural mating such that the line needs to be propagated by ovary transplantation. Young heterozygotes adults in video-EEG also exhibit very frequent interictal epileptiform spiking and spike-wave discharge activity, resembling absence seizures. Preliminary histology shows significant pyknotic nuclei appearing to evidence
cell death in the cerebral cortex. Pup developmental milestones, while not evidencing significant developmental delay, show unusual features including excessive maternal separation induced pup vocalization. Further studies are ongoing. Together these efforts illustrate the power of modelling severe neurodevelopmental seizure disorders using multiple experimental modalities and suggest their utility in identifying and evaluating new therapies.
Bioinformatics core services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
Bioinformatics core services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
Bioinformatics Core Services, the IBMCP casejavijevi
Description of the work done at the Bioinformatics Core Service of the Institute for Plant Molecular and Cell Biology (Instituto de Biología Molecular y Celular de Plantas, IBMCP,www.ibmcp.upv.es). The IBMCP is a research center of the Polytechnic University of Valencia (Universidad Politécnica de Valencia, UPV, www.upv.es) and the Spanish Research Council (Consejo Superior de Investigaciones Científicas, CSIC, www.csic.es) of Spain.
A simple presentation on the Lassa fever endemic in Nigeria - from its first discovery in a town called Lassa in northeastern Nigeria, the mode of transmission, to the control and prevention measures that can be applied to curbing the spread of the virus. Suitable for rural sensitization.
Excerpt from CDC -- [Signs & symptoms]
Signs and symptoms of Lassa fever typically occur 1-3 weeks after the patient comes into contact with the virus. For the majority of Lassa fever virus infections (approximately 80%), symptoms are mild and are undiagnosed. Mild symptoms include slight fever, general malaise and weakness, and headache. In 20% of infected individuals, however, disease may progress to more serious symptoms including hemorrhaging (in gums, eyes, or nose, as examples), respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, and shock. Neurological problems have also been described, including hearing loss, tremors, and encephalitis. Death may occur within two weeks after symptom onset due to multi-organ failure.
The most common complication of Lassa fever is deafness. Various degrees of deafness occur in approximately one-third of infections, and in many cases hearing loss is permanent. As far as is known, severity of the disease does not affect this complication: deafness may develop in mild as well as in severe cases.
Approximately 15%-20% of patients hospitalized for Lassa fever die from the illness. However, only 1% of all Lassa virus infections result in death. The death rates for women in the third trimester of pregnancy are particularly high. Spontaneous abortion is a serious complication of infection with an estimated 95% mortality in fetuses of infected pregnant mothers.
Because the symptoms of Lassa fever are so varied and nonspecific, clinical diagnosis is often difficult. Lassa fever is also associated with occasional epidemics, during which the case-fatality rate can reach 50% in hospitalized patients.
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...Quality Assistance s.a.
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiques par LC/MS par Arnaud Delobel, R&D Director
Visit www.quality-assistance.com for more information
Advances in LC/MS methodologies for the characterisation of complex glycoprot...Quality Assistance s.a.
Dr. Arnaud Delobel from Quality Assistance spoke on "Advances in LC/MS methodologies for the characterisation of complex glycoproteins (case study: Etanercept)" at the "Challenges and Opportunities in Protein Analytics" day in Brussels.
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...Ann-Marie Roche
In this 60 minute webinar, Philip L. Lorenzi Ph.D. talked to us about autophagy, a programmed process in which cell contents are delivered to lysosomes for degradation and which appears to have both tumor-suppressive and tumor-promoting functions. Phillip and his colleagues have compiled a comprehensive, curated inventory of autophagy modulators by integrating information from published siRNA screens, multiple pathway analysis algorithms, and extensive text-mining of the literature and he will provide extensive analysis of their sources of information and their complex relationships with each other.
Development of a Multi-Variant Frequency Ladder™ for Next Generation Sequenci...Thermo Fisher Scientific
Increasing adoption of NGS has shed light on the need for more
standardized controls to evaluate and optimize system performance.
Samples containing mutations of interest are difficult to source and cell
line pooling experiments to determine limit of detection require significant
investments of time and money. To simultaneously evaluate variant
calling performance in >200 unique amplicons across 50 genes targeted
by NGS tests, AcroMetrix® has developed a proprietary
genomic/synthetic DNA material containing over 550 mutations as a
mixture of SNV’s indels and MNP’s. The limit of detection was then
determined for >400 variants using multiple platforms. Tumor samples
were diluted with matched normal samples to mimic a range of
frequencies. Linearity between the material and diluted tumor tissue
samples were compared. Overall, highly multiplex controls with tunable
frequencies allow for much more extensive, yet streamlined, assay
evaluation and facilitate implementation and impart confidence to NGS
testing.
Dr. José Baselga - Simposio Internacional 'Terapias oncológicas avanzadas'Fundación Ramón Areces
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
A Spanish Daily Routine for People Who Struggle with Daily RoutinesNacho Caballero
Most people would agree that having a daily practice routine helps you learn Spanish faster. However, when we try to stick to an actual routine, we tend to drop it after a few days.
Why does this happen?
In the associated video (http://bit.ly/nachotime_dailyroutine) I share a technique that has given me consistency super powers: planning what you want to do on a piece of paper, doing what you can and tracking what you actually did.
Download the guide: https://itsnachotime.com/dailyroutine/
Creating effective slides without having to become a graphic designerNacho Caballero
This is session 3 of the Awesome Presentations Workshop. You can watch the video for session 2 (developing the story) at https://www.youtube.com/watch?v=jC1glujAhZI
The purpose of a slide is to illustrate an important point in the story. Without a clear story it's impossible to create an effective slide. Once you know what you want to say, notice all the things in your slide and ask why.
Image credit from the Noun Project
Winner by Juan Pablo Bravo
Sadness by Juan Pablo Bravo
Rock Climbing by Paul Phillips
Walking by Dmitriy Lagunov
Man by Matt Brooks
BMX by Marc Serre
How to Build Compelling Research Stories That People Will RememberNacho Caballero
Video: https://www.youtube.com/watch?v=jC1glujAhZI
Session 2 of the Awesome Presentations Workshop
We remember things that surprise us. We remember things that we enjoy. Mostly, we remember things that we understand. Being understood is the main reason to give a presentation, and also its biggest challenge.
Image credits from the Noun Project:
Folder by Sergio Calcara
File by Pham Thi Dieu Linh
Sleep by DonBLC 123
Mountain by Philip Joyce
Beret by Einxel Reyes
Sheriff Hat by Camila Bertoco
Lab meeting presentation about my work doing viral metagenomics in French Guiana
Rat by Francisca Arévalo from The Noun Project
Bat by Adam Heller from The Noun Project
I was invited to give a short presentation about the tools that I use for my research in Cayenne, French Guiana (sickle, velvet, digital normalization (khmer), krona, awk and others).
Bridging data analysis and interactive visualizationNacho Caballero
Clickme is an R package that lets you generate interactive visualizations directly from R. I presented the latest iteration at the 2013 IBSB conference in Kyoto
More Related Content
Similar to Lassa virus detection using gene expression analysis
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...Quality Assistance s.a.
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiques par LC/MS par Arnaud Delobel, R&D Director
Visit www.quality-assistance.com for more information
Advances in LC/MS methodologies for the characterisation of complex glycoprot...Quality Assistance s.a.
Dr. Arnaud Delobel from Quality Assistance spoke on "Advances in LC/MS methodologies for the characterisation of complex glycoproteins (case study: Etanercept)" at the "Challenges and Opportunities in Protein Analytics" day in Brussels.
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...Ann-Marie Roche
In this 60 minute webinar, Philip L. Lorenzi Ph.D. talked to us about autophagy, a programmed process in which cell contents are delivered to lysosomes for degradation and which appears to have both tumor-suppressive and tumor-promoting functions. Phillip and his colleagues have compiled a comprehensive, curated inventory of autophagy modulators by integrating information from published siRNA screens, multiple pathway analysis algorithms, and extensive text-mining of the literature and he will provide extensive analysis of their sources of information and their complex relationships with each other.
Development of a Multi-Variant Frequency Ladder™ for Next Generation Sequenci...Thermo Fisher Scientific
Increasing adoption of NGS has shed light on the need for more
standardized controls to evaluate and optimize system performance.
Samples containing mutations of interest are difficult to source and cell
line pooling experiments to determine limit of detection require significant
investments of time and money. To simultaneously evaluate variant
calling performance in >200 unique amplicons across 50 genes targeted
by NGS tests, AcroMetrix® has developed a proprietary
genomic/synthetic DNA material containing over 550 mutations as a
mixture of SNV’s indels and MNP’s. The limit of detection was then
determined for >400 variants using multiple platforms. Tumor samples
were diluted with matched normal samples to mimic a range of
frequencies. Linearity between the material and diluted tumor tissue
samples were compared. Overall, highly multiplex controls with tunable
frequencies allow for much more extensive, yet streamlined, assay
evaluation and facilitate implementation and impart confidence to NGS
testing.
Dr. José Baselga - Simposio Internacional 'Terapias oncológicas avanzadas'Fundación Ramón Areces
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
A Spanish Daily Routine for People Who Struggle with Daily RoutinesNacho Caballero
Most people would agree that having a daily practice routine helps you learn Spanish faster. However, when we try to stick to an actual routine, we tend to drop it after a few days.
Why does this happen?
In the associated video (http://bit.ly/nachotime_dailyroutine) I share a technique that has given me consistency super powers: planning what you want to do on a piece of paper, doing what you can and tracking what you actually did.
Download the guide: https://itsnachotime.com/dailyroutine/
Creating effective slides without having to become a graphic designerNacho Caballero
This is session 3 of the Awesome Presentations Workshop. You can watch the video for session 2 (developing the story) at https://www.youtube.com/watch?v=jC1glujAhZI
The purpose of a slide is to illustrate an important point in the story. Without a clear story it's impossible to create an effective slide. Once you know what you want to say, notice all the things in your slide and ask why.
Image credit from the Noun Project
Winner by Juan Pablo Bravo
Sadness by Juan Pablo Bravo
Rock Climbing by Paul Phillips
Walking by Dmitriy Lagunov
Man by Matt Brooks
BMX by Marc Serre
How to Build Compelling Research Stories That People Will RememberNacho Caballero
Video: https://www.youtube.com/watch?v=jC1glujAhZI
Session 2 of the Awesome Presentations Workshop
We remember things that surprise us. We remember things that we enjoy. Mostly, we remember things that we understand. Being understood is the main reason to give a presentation, and also its biggest challenge.
Image credits from the Noun Project:
Folder by Sergio Calcara
File by Pham Thi Dieu Linh
Sleep by DonBLC 123
Mountain by Philip Joyce
Beret by Einxel Reyes
Sheriff Hat by Camila Bertoco
Lab meeting presentation about my work doing viral metagenomics in French Guiana
Rat by Francisca Arévalo from The Noun Project
Bat by Adam Heller from The Noun Project
I was invited to give a short presentation about the tools that I use for my research in Cayenne, French Guiana (sickle, velvet, digital normalization (khmer), krona, awk and others).
Bridging data analysis and interactive visualizationNacho Caballero
Clickme is an R package that lets you generate interactive visualizations directly from R. I presented the latest iteration at the 2013 IBSB conference in Kyoto
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
PHP Frameworks: I want to break free (IPC Berlin 2024)Ralf Eggert
In this presentation, we examine the challenges and limitations of relying too heavily on PHP frameworks in web development. We discuss the history of PHP and its frameworks to understand how this dependence has evolved. The focus will be on providing concrete tips and strategies to reduce reliance on these frameworks, based on real-world examples and practical considerations. The goal is to equip developers with the skills and knowledge to create more flexible and future-proof web applications. We'll explore the importance of maintaining autonomy in a rapidly changing tech landscape and how to make informed decisions in PHP development.
This talk is aimed at encouraging a more independent approach to using PHP frameworks, moving towards a more flexible and future-proof approach to PHP development.
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on the notifications, alerts, and approval requests using Slack for Bonterra Impact Management. The solutions covered in this webinar can also be deployed for Microsoft Teams.
Interested in deploying notification automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Key Trends Shaping the Future of Infrastructure.pdfCheryl Hung
Keynote at DIGIT West Expo, Glasgow on 29 May 2024.
Cheryl Hung, ochery.com
Sr Director, Infrastructure Ecosystem, Arm.
The key trends across hardware, cloud and open-source; exploring how these areas are likely to mature and develop over the short and long-term, and then considering how organisations can position themselves to adapt and thrive.
Let's dive deeper into the world of ODC! Ricardo Alves (OutSystems) will join us to tell all about the new Data Fabric. After that, Sezen de Bruijn (OutSystems) will get into the details on how to best design a sturdy architecture within ODC.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
8. Log Fold
Change
3 DPI vs Pre
=
3 days post
infection
Pre Infection
P-value
depends on
number of
individuals
variance of
individual
log ratios
magnitude
of log fold
change
10. Pre
3 DPI
vs
Pre
6 DPI
vs
Pre 8 DPI
vs
Pre
10 DPI
vs
Pre
12 DPI
vs
Pre
Probes with
significant
p-values at
3 DPI
vs
Pre
2
11. 2
Pre
3 DPI
vs
Pre
6 DPI
vs
Pre 8 DPI
vs
Pre
10 DPI
vs
Pre
12 DPI
vs
Pre
Probes with
significant
p-values at
3 DPI
vs
Pre
and
sustained
log fold
changes